Associação de cultura e diversidade genética de Candida com características clínicas e epidemiológicas de pacientes com diagnóstico de candidíase vulvovaginal
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora
DOI
Abstract
The vulvovaginal candidiases (VVC) is one of the most frequent diagnosed disease
in gynecological practice and its incidence has increased drastically. Therefore,
regional prospective studies become necessary to better address epidemiological
issues. It has been recognized the emergence of other yeast species, besides
Candida albicans, as VVC in mono or polymicrobial infections, with direct reflex in
antifungal therapy, often empirical. This study was focused on the etiology
investigation, the epidemiological profile of patients with vulvovaginal candidiasis
(VVC) and predisposing factors, addition to the genetic diversity of yeasts. Vaginal
secretions were streaked in Sabouraud agar and yeast samples were isolated and
identified by PCR. Demographic and clinical data were obtained by questionnaire.
For statistical analysis the Student t test, chi-square and Fischer, were applied as
needed using the software Statistical Package for Social Sciences (SPSS) with a
significance level of 5 %. Yeast genotyping was performed by the RAPD approach,
and a similarity matrix was obtained to evaluate C. albicans diversity and their
relationships with clinical and epidemiological data. Sixty nine patients were
evaluated between 15 and 52 years, predominantly white (79.7 %), with higher
education (58 %), married (56.5 %) and sexually active (97.1 %). Among them, 34.8
% were pregnant, 7.2% diabetic, 1.4 % seropositive for HIV and 36.2 % using oral
contraceptives. Recent antibiotic therapy was mentioned by 13 % of patients, and
antifungal or anti-trichomonas therapy were mentioned by 5.8% and 1.4 % of the
patients. Corticosteroid use was reported by 2.9 % and antineoplastic by 1.4 %.
Vaginal discharge and itching were the main complaints (97.1 % and 73.9 %),
followed by burning (63.8 %) and erythema (63.8 %). When present, the vaginal flow
was predominantly white (88.1 %) or lumpy (86.6 %). The diagnosis was confirmed
by culture in 55 (79.7 %) patients, with mixed infections in four patients. The most
prevalent species was C. albicans, followed by C. glabrata (one monoinfection and
two mixed infections with C. albicans). C. lusitaniae and C. albicans were also
identified in mixed infections (two patients). The analysis of data generated by yeasts
genotyping allowed discriminating different C. albicans strains in the sampled
population. It was identified seven electrophoretic types (ET) classified within groups
I to VII. The groups I, II, III, IV, V and VI included yeast strains with of 100% genetic
similarity. In group VII were included the yeast strains highly polymorphic that present
less than 80% of similarity. Despite the high culture positivity and clinical data being
characteristic of VVC, the symptoms are not pathognomonic. C. albicans is the most
prevalent species, but other species are also involved in the VVC etiology, as the
emergence of C. lusitaniae. It is suggested the diagnosis and identification of
microbial species involved including detection of mixed infections before antimicrobial
chemotherapy.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
